ENTRY       hsa05017                    Pathway
NAME        Spinocerebellar ataxia - Homo sapiens (human)
DESCRIPTION The autosomal dominant spinocerebellar ataxias (SCAs) are a group of progressive neurodegenerative diseases characterised by loss of balance and motor coordination due to the primary dysfunction of the cerebellum. Compelling evidence points to major aetiological roles for transcriptional dysregulation, protein aggregation and clearance, autophagy, the ubiquitin-proteasome system, alterations of calcium homeostasis, mitochondria defects, toxic RNA gain-of-function mechanisms and eventual cell death with apoptotic features of neurons during SCA disease progression.
CLASS       Human Diseases; Neurodegenerative disease
PATHWAY_MAP hsa05017  Spinocerebellar ataxia
NETWORK     nt06462  Spinocerebellar ataxia
            nt06466  Pathways of neurodegeneration
  ELEMENT   N00954  Mutation-activated GRM1 to mGluR1-TRPC3 signaling pathway
            N00955  Mutation-inactivated PRKCG to mGluR1-TRPC3 signaling pathway
            N00956  Mutation-activated PRKCG to mGluR1-TRPC3 signaling pathway
            N00957  Mutation-caused abberant ATXN2/3 to mGluR5-Ca2+ -apoptotic pathway
            N00958  Mutation-activated ITPR1 to mGluR1-TRPC3 signaling pathway
            N00959  ITPR1-reduced expression to mGluR1-TRPC3 signaling pathway
            N00960  Mutation-caused aberrant SPTBN2 to mGluR1-TRPC3 signaling pathway
            N00961  Mutation-activated TRPC3 to mGluR1-TRPC3 signaling pathway
            N00962  Mutation-inactivated ATXN3 to autophagy-vesicle nucleation
            N00964  DAB1-overexpression to RELN-VLDLR-PI3K signaling pathway
            N00966  Mutation-caused aberrant ATXN1 to RORA-mediated transcription
            N00968  Mutation-activated CACNA1A to VGCC-Ca2+ -apoptotic pathway
            N00969  Mutation-inactivated CACNA1A to VGCC-Ca2- -apoptotic pathway
            N00971  Mutation-caused aberrant PDYN to transport of calcium
            N00973  Mutation-inactivated KCNC3 to transport of potassium
            N00975  Mutation-inactivated KCND3 to transport of potassium
DISEASE     H00063  Spinocerebellar ataxia (SCA)
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
            10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]
            10213  PSMD14; proteasome 26S subunit, non-ATPase 14 [KO:K03030]
            10524  KAT5; lysine acetyltransferase 5 [KO:K11304] [EC:2.3.1.48]
            10528  NOP56; NOP56 ribonucleoprotein [KO:K14564]
            10939  AFG3L2; AFG3 like matrix AAA peptidase subunit 2 [KO:K08956] [EC:3.4.24.-]
            110117499  P3R3URF-PIK3R3; P3R3URF-PIK3R3 readthrough [KO:K02649]
            11047  ADRM1; ADRM1 26S proteasome ubiquitin receptor [KO:K06691]
            11273  ATXN2L; ataxin 2 like [KO:K23625]
            11317  RBPJL; recombination signal binding protein for immunoglobulin kappa J region like [KO:K06053]
            115209  OMA1; OMA1 zinc metallopeptidase [KO:K23010]
            116443  GRIN3A; glutamate ionotropic receptor NMDA type subunit 3A [KO:K05213]
            116444  GRIN3B; glutamate ionotropic receptor NMDA type subunit 3B [KO:K05214]
            143471  PSMA8; proteasome 20S subunit alpha 8 [KO:K02731] [EC:3.4.25.1]
            146227  BEAN1; brain expressed associated with NEDD4 1 [KO:K19324]
            1600  DAB1; DAB adaptor protein 1 [KO:K20054]
            207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
            2081  ERN1; endoplasmic reticulum to nucleus signaling 1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]
            2259  FGF14; fibroblast growth factor 14 [KO:K23920]
            22863  ATG14; autophagy related 14 [KO:K17889]
            23130  ATG2A; autophagy related 2A [KO:K17906]
            23152  CIC; capicua transcriptional repressor [KO:K20225]
            23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]
            23369  PUM2; pumilio RNA binding family member 2 [KO:K17943]
            2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]
            25814  ATXN10; ataxin 10 [KO:K19323]
            26100  WIPI2; WD repeat domain, phosphoinositide interacting 2 [KO:K17908]
            2776  GNAQ; G protein subunit alpha q [KO:K04634]
            2890  GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197]
            2891  GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198]
            2892  GRIA3; glutamate ionotropic receptor AMPA type subunit 3 [KO:K05199]
            2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]
            2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]
            2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]
            2905  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]
            2906  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]
            291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]
            2911  GRM1; glutamate metabotropic receptor 1 [KO:K04603]
            292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]
            293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]
            2959  GTF2B; general transcription factor IIB [KO:K03124]
            29982  NRBF2; nuclear receptor binding factor 2 [KO:K21246]
            30849  PIK3R4; phosphoinositide-3-kinase regulatory subunit 4 [KO:K08333] [EC:2.7.11.1]
            342371  ATXN1L; ataxin 1 like [KO:K23616]
            3516  RBPJ; recombination signal binding protein for immunoglobulin kappa J region [KO:K06053]
            3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
            3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
            3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
            3748  KCNC3; potassium voltage-gated channel subfamily C member 3 [KO:K04889]
            3752  KCND3; potassium voltage-gated channel subfamily D member 3 [KO:K04893]
            387332  TBPL2; TATA-box binding protein like 2 [KO:K03120]
            4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]
            4287  ATXN3; ataxin 3 [KO:K11863] [EC:3.4.22.-]
            441925  BECN2; beclin 2 [KO:K08334]
            4654  MYOD1; myogenic differentiation 1 [KO:K09064]
            4800  NFYA; nuclear transcription factor Y subunit alpha [KO:K08064]
            487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]
            488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]
            489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]
            4976  OPA1; OPA1 mitochondrial dynamin like GTPase [KO:K17079] [EC:3.6.5.5]
            5173  PDYN; prodynorphin [KO:K15840]
            5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]
            5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]
            5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]
            54205  CYCS; cytochrome c, somatic [KO:K08738]
            55062  WIPI1; WD repeat domain, phosphoinositide interacting 1 [KO:K17908]
            55102  ATG2B; autophagy related 2B [KO:K17906]
            55626  AMBRA1; autophagy and beclin 1 regulator 1 [KO:K17985]
            5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
            5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
            5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
            5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            5649  RELN; reelin [KO:K06249] [EC:3.4.21.-]
            56652  TWNK; twinkle mtDNA helicase [KO:K17680] [EC:5.6.2.3]
            5682  PSMA1; proteasome 20S subunit alpha 1 [KO:K02725] [EC:3.4.25.1]
            5683  PSMA2; proteasome 20S subunit alpha 2 [KO:K02726] [EC:3.4.25.1]
            5684  PSMA3; proteasome 20S subunit alpha 3 [KO:K02727] [EC:3.4.25.1]
            5685  PSMA4; proteasome 20S subunit alpha 4 [KO:K02728] [EC:3.4.25.1]
            5686  PSMA5; proteasome 20S subunit alpha 5 [KO:K02729] [EC:3.4.25.1]
            5687  PSMA6; proteasome 20S subunit alpha 6 [KO:K02730] [EC:3.4.25.1]
            5688  PSMA7; proteasome 20S subunit alpha 7 [KO:K02731] [EC:3.4.25.1]
            5689  PSMB1; proteasome 20S subunit beta 1 [KO:K02732] [EC:3.4.25.1]
            5690  PSMB2; proteasome 20S subunit beta 2 [KO:K02734] [EC:3.4.25.1]
            5691  PSMB3; proteasome 20S subunit beta 3 [KO:K02735] [EC:3.4.25.1]
            5692  PSMB4; proteasome 20S subunit beta 4 [KO:K02736] [EC:3.4.25.1]
            5693  PSMB5; proteasome 20S subunit beta 5 [KO:K02737] [EC:3.4.25.1]
            5694  PSMB6; proteasome 20S subunit beta 6 [KO:K02738] [EC:3.4.25.1]
            5695  PSMB7; proteasome 20S subunit beta 7 [KO:K02739] [EC:3.4.25.1]
            5700  PSMC1; proteasome 26S subunit, ATPase 1 [KO:K03062]
            5701  PSMC2; proteasome 26S subunit, ATPase 2 [KO:K03061]
            5702  PSMC3; proteasome 26S subunit, ATPase 3 [KO:K03065]
            5704  PSMC4; proteasome 26S subunit, ATPase 4 [KO:K03063]
            5705  PSMC5; proteasome 26S subunit, ATPase 5 [KO:K03066]
            5706  PSMC6; proteasome 26S subunit, ATPase 6 [KO:K03064]
            5707  PSMD1; proteasome 26S subunit, non-ATPase 1 [KO:K03032]
            5708  PSMD2; proteasome 26S subunit ubiquitin receptor, non-ATPase 2 [KO:K03028]
            5709  PSMD3; proteasome 26S subunit, non-ATPase 3 [KO:K03033]
            5710  PSMD4; proteasome 26S subunit ubiquitin receptor, non-ATPase 4 [KO:K03029]
            5713  PSMD7; proteasome 26S subunit, non-ATPase 7 [KO:K03038]
            5714  PSMD8; proteasome 26S subunit, non-ATPase 8 [KO:K03031]
            5715  PSMD9; proteasome 26S subunit, non-ATPase 9 [KO:K06693]
            5717  PSMD11; proteasome 26S subunit, non-ATPase 11 [KO:K03036]
            5718  PSMD12; proteasome 26S subunit, non-ATPase 12 [KO:K03035]
            5719  PSMD13; proteasome 26S subunit, non-ATPase 13 [KO:K03039]
            60673  ATG101; autophagy related 101 [KO:K19730]
            6095  RORA; RAR related orphan receptor A [KO:K08532]
            6261  RYR1; ryanodine receptor 1 [KO:K04961]
            6310  ATXN1; ataxin 1 [KO:K23616]
            6311  ATXN2; ataxin 2 [KO:K23625]
            6315  ATXN8OS; ATXN8 opposite strand lncRNA [KO:K23933]
            6511  SLC1A6; solute carrier family 1 member 6 [KO:K05617]
            6667  SP1; Sp1 transcription factor [KO:K04684]
            6712  SPTBN2; spectrin beta, non-erythrocytic 2 [KO:K23932]
            6908  TBP; TATA-box binding protein [KO:K03120]
            7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]
            7222  TRPC3; transient receptor potential cation channel subfamily C member 3 [KO:K04966]
            7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]
            7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]
            7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]
            7436  VLDLR; very low density lipoprotein receptor [KO:K20053]
            7494  XBP1; X-box binding protein 1 [KO:K09027]
            773  CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344]
            7979  SEM1; SEM1 26S proteasome subunit [KO:K10881]
            83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]
            8408  ULK1; unc-51 like autophagy activating kinase 1 [KO:K21357] [EC:2.7.11.1]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            8678  BECN1; beclin 1 [KO:K08334]
            90550  MCU; mitochondrial calcium uniporter [KO:K20858]
            92552  ATXN3L; ataxin 3 like [KO:K11863] [EC:3.4.22.-]
            9519  TBPL1; TATA-box binding protein like 1 [KO:K03120]
            9698  PUM1; pumilio RNA binding family member 1 [KO:K17943]
            9706  ULK2; unc-51 like autophagy activating kinase 2 [KO:K08269] [EC:2.7.11.1]
            9776  ATG13; autophagy related 13 [KO:K08331]
            9821  RB1CC1; RB1 inducible coiled-coil 1 [KO:K17589]
            9861  PSMD6; proteasome 26S subunit, non-ATPase 6 [KO:K03037]
COMPOUND    C00025  L-Glutamate
            C00076  Calcium cation
            C00165  Diacylglycerol
            C00238  Potassium cation
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C01330  Sodium cation
            C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate
REFERENCE   PMID:19890685
  AUTHORS   Matilla-Duenas A, Sanchez I, Corral-Juan M, Davalos A, Alvarez R, Latorre P
  TITLE     Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.
  JOURNAL   Cerebellum 9:148-66 (2010)
            DOI:10.1007/s12311-009-0144-2
REFERENCE   PMID:16613893
  AUTHORS   Duenas AM, Goold R, Giunti P
  TITLE     Molecular pathogenesis of spinocerebellar ataxias.
  JOURNAL   Brain 129:1357-70 (2006)
            DOI:10.1093/brain/awl081
REFERENCE   PMID:27392710
  AUTHORS   Mark MD, Schwitalla JC, Groemmke M, Herlitze S
  TITLE     Keeping Our Calcium in Balance to Maintain Our Balance.
  JOURNAL   Biochem Biophys Res Commun 483:1040-1050 (2017)
            DOI:10.1016/j.bbrc.2016.07.020
REFERENCE   PMID:29253316
  AUTHORS   Egorova PA, Bezprozvanny IB
  TITLE     Inositol 1,4,5-trisphosphate receptors and neurodegenerative disorders.
  JOURNAL   FEBS J 285:3547-3565 (2018)
            DOI:10.1111/febs.14366
REFERENCE   PMID:28554312
  AUTHORS   Shimobayashi E, Kapfhammer JP
  TITLE     Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development.
  JOURNAL   Curr Neuropharmacol 16:151-159 (2018)
            DOI:10.2174/1570159X15666170529104000
REFERENCE   PMID:20480274
  AUTHORS   Kasumu A, Bezprozvanny I
  TITLE     Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.
  JOURNAL   Cerebellum 11:630-9 (2012)
            DOI:10.1007/s12311-010-0182-9
REFERENCE   PMID:25846864
  AUTHORS   Egorova P, Popugaeva E, Bezprozvanny I
  TITLE     Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer's disease.
  JOURNAL   Semin Cell Dev Biol 40:127-33 (2015)
            DOI:10.1016/j.semcdb.2015.03.010
REFERENCE   PMID:29777722
  AUTHORS   Hisatsune C, Hamada K, Mikoshiba K
  TITLE     Ca(2+) signaling and spinocerebellar ataxia.
  JOURNAL   Biochim Biophys Acta Mol Cell Res 1865:1733-1744 (2018)
            DOI:10.1016/j.bbamcr.2018.05.009
REFERENCE   PMID:27771899
  AUTHORS   Takada SH, Ikebara JM, de Sousa E, Cardoso DS, Resende RR, Ulrich H, Ruckl M, Rudiger S, Kihara AH
  TITLE     Determining the Roles of Inositol Trisphosphate Receptors in Neurodegeneration: Interdisciplinary Perspectives on a Complex Topic.
  JOURNAL   Mol Neurobiol 54:6870-6884 (2017)
            DOI:10.1007/s12035-016-0205-8
REFERENCE   PMID:25653583
  AUTHORS   Brown SA, Loew LM
  TITLE     Integration of modeling with experimental and clinical findings synthesizes and refines the central role of inositol 1,4,5-trisphosphate receptor 1 in spinocerebellar ataxia.
  JOURNAL   Front Neurosci 8:453 (2014)
            DOI:10.3389/fnins.2014.00453
REFERENCE   PMID:14748477
  AUTHORS   Inoue T
  TITLE     Dynamics of calcium and its roles in the dendrite of the cerebellar Purkinje cell.
  JOURNAL   Keio J Med 52:244-9 (2003)
            DOI:10.2302/kjm.52.244
REFERENCE   PMID:18499672
  AUTHORS   Adachi N, Kobayashi T, Takahashi H, Kawasaki T, Shirai Y, Ueyama T, Matsuda T, Seki T, Sakai N, Saito N
  TITLE     Enzymological analysis of mutant protein kinase Cgamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis.
  JOURNAL   J Biol Chem 283:19854-63 (2008)
            DOI:10.1074/jbc.M801492200
REFERENCE   PMID:26169942
  AUTHORS   Smeets CJ, Jezierska J, Watanabe H, Duarri A, Fokkens MR, Meijer M, Zhou Q, Yakovleva T, Boddeke E, den Dunnen W, van Deursen J, Bakalkin G, Kampinga HH, van de Sluis B, Verbeek DS
  TITLE     Elevated mutant dynorphin A causes Purkinje cell loss and motor dysfunction in spinocerebellar ataxia type 23.
  JOURNAL   Brain 138:2537-52 (2015)
            DOI:10.1093/brain/awv195
REFERENCE   PMID:30910913
  AUTHORS   Tulli S, Del Bondio A, Baderna V, Mazza D, Codazzi F, Pierson TM, Ambrosi A, Nolte D, Goizet C, Toro C, Baets J, Deconinck T, DeJonghe P, Mandich P, Casari G, Maltecca F
  TITLE     Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation.
  JOURNAL   J Med Genet 56:499-511 (2019)
            DOI:10.1136/jmedgenet-2018-105766
REFERENCE   PMID:30389403
  AUTHORS   Mancini C, Hoxha E, Iommarini L, Brussino A, Richter U, Montarolo F, Cagnoli C, Parolisi R, Gondor Morosini DI, Nicolo V, Maltecca F, Muratori L, Ronchi G, Geuna S, Arnaboldi F, Donetti E, Giorgio E, Cavalieri S, Di Gregorio E, Pozzi E, Ferrero M, Riberi E, Casari G, Altruda F, Turco E, Gasparre G, Battersby BJ, Porcelli AM, Ferrero E, Brusco A, Tempia F
  TITLE     Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.
  JOURNAL   Neurobiol Dis 124:14-28 (2019)
            DOI:10.1016/j.nbd.2018.10.018
REFERENCE   PMID:25772041
  AUTHORS   Becker EBE
  TITLE     From Mice to Men: TRPC3 in Cerebellar Ataxia.
  JOURNAL   Cerebellum 16:877-879 (2017)
            DOI:10.1007/s12311-015-0663-y
REFERENCE   PMID:27857688
  AUTHORS   Hoxha E, Tempia F, Lippiello P, Miniaci MC
  TITLE     Modulation, Plasticity and Pathophysiology of the Parallel Fiber-Purkinje Cell Synapse.
  JOURNAL   Front Synaptic Neurosci 8:35 (2016)
            DOI:10.3389/fnsyn.2016.00035
REFERENCE   PMID:23831029
  AUTHORS   Yan H, Pablo JL, Pitt GS
  TITLE     FGF14 regulates presynaptic Ca2+ channels and synaptic transmission.
  JOURNAL   Cell Rep 4:66-75 (2013)
            DOI:10.1016/j.celrep.2013.06.012
REFERENCE   PMID:26827887
  AUTHORS   Tada M, Nishizawa M, Onodera O
  TITLE     Roles of inositol 1,4,5-trisphosphate receptors in spinocerebellar ataxias.
  JOURNAL   Neurochem Int 94:1-8 (2016)
            DOI:10.1016/j.neuint.2016.01.007
REFERENCE   PMID:20204399
  AUTHORS   Pietrobon D
  TITLE     CaV2.1 channelopathies.
  JOURNAL   Pflugers Arch 460:375-93 (2010)
            DOI:10.1007/s00424-010-0802-8
REFERENCE   PMID:15474358
  AUTHORS   Matsuyama Z, Yanagisawa NK, Aoki Y, Black JL 3rd, Lennon VA, Mori Y, Imoto K, Inuzuka T
  TITLE     Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of CaV2.1 Ca2+ channel--loss-of-function cellular model of SCA6.
  JOURNAL   Neurobiol Dis 17:198-204 (2004)
            DOI:10.1016/j.nbd.2004.07.013
REFERENCE   PMID:12050113
  AUTHORS   Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A, Ichijo H
  TITLE     ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats.
  JOURNAL   Genes Dev 16:1345-55 (2002)
            DOI:10.1101/gad.992302
REFERENCE   PMID:24293103
  AUTHORS   Evers MM, Toonen LJ, van Roon-Mom WM
  TITLE     Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.
  JOURNAL   Mol Neurobiol 49:1513-31 (2014)
            DOI:10.1007/s12035-013-8596-2
REFERENCE   PMID:28722507
  AUTHORS   Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC, Imarisio S, Menzies FM, Rubinsztein DC
  TITLE     Polyglutamine tracts regulate autophagy.
  JOURNAL   Autophagy 13:1613-1614 (2017)
            DOI:10.1080/15548627.2017.1336278
REFERENCE   PMID:31630678
  AUTHORS   Chen RH, Chen YH, Huang TY
  TITLE     Ubiquitin-mediated regulation of autophagy.
  JOURNAL   J Biomed Sci 26:80 (2019)
            DOI:10.1186/s12929-019-0569-y
REFERENCE   PMID:17110330
  AUTHORS   Serra HG, Duvick L, Zu T, Carlson K, Stevens S, Jorgensen N, Lysholm A, Burright E, Zoghbi HY, Clark HB, Andresen JM, Orr HT
  TITLE     RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.
  JOURNAL   Cell 127:697-708 (2006)
            DOI:10.1016/j.cell.2006.09.036
REFERENCE   PMID:29526553
  AUTHORS   Rousseaux MWC, Tschumperlin T, Lu HC, Lackey EP, Bondar VV, Wan YW, Tan Q, Adamski CJ, Friedrich J, Twaroski K, Chen W, Tolar J, Henzler C, Sharma A, Bajic A, Lin T, Duvick L, Liu Z, Sillitoe RV, Zoghbi HY, Orr HT
  TITLE     ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.
  JOURNAL   Neuron 97:1235-1243.e5 (2018)
            DOI:10.1016/j.neuron.2018.02.013
REFERENCE   PMID:22526417
  AUTHORS   Jimenez G, Shvartsman SY, Paroush Z
  TITLE     The Capicua repressor--a general sensor of RTK signaling in development and disease.
  JOURNAL   J Cell Sci 125:1383-91 (2012)
            DOI:10.1242/jcs.092965
REFERENCE   PMID:29474920
  AUTHORS   Gennarino VA, Palmer EE, McDonell LM, Wang L, Adamski CJ, Koire A, See L, Chen CA, Schaaf CP, Rosenfeld JA, Panzer JA, Moog U, Hao S, Bye A, Kirk EP, Stankiewicz P, Breman AM, McBride A, Kandula T, Dubbs HA, Macintosh R, Cardamone M, Zhu Y, Ying K, Dias KR, Cho MT, Henderson LB, Baskin B, Morris P, Tao J, Cowley MJ, Dinger ME, Roscioli T, Caluseriu O, Suchowersky O, Sachdev RK, Lichtarge O, Tang J, Boycott KM, Holder JL Jr, Zoghbi HY
  TITLE     A Mild PUM1 Mutation Is Associated with Adult-Onset Ataxia, whereas Haploinsufficiency Causes Developmental Delay and Seizures.
  JOURNAL   Cell 172:924-936.e11 (2018)
            DOI:10.1016/j.cell.2018.02.006
REFERENCE   PMID:24218544
  AUTHORS   Irie T, Matsuzaki Y, Sekino Y, Hirai H
  TITLE     Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells.
  JOURNAL   J Physiol 592:229-47 (2014)
            DOI:10.1113/jphysiol.2013.264309
REFERENCE   PMID:26889478
  AUTHORS   Bushart DD, Murphy GG, Shakkottai VG
  TITLE     Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease.
  JOURNAL   Ann Transl Med 4:25 (2016)
            DOI:10.3978/j.issn.2305-5839.2016.01.06
REFERENCE   PMID:31293010
  AUTHORS   Hsiao CT, Fu SJ, Liu YT, Lu YH, Zhong CY, Tang CY, Soong BW, Jeng CJ
  TITLE     Novel SCA19/22-associated KCND3 mutations disrupt human KV 4.3 protein biosynthesis and channel gating.
  JOURNAL   Hum Mutat 40:2088-2107 (2019)
            DOI:10.1002/humu.23865
REFERENCE   PMID:25854634
  AUTHORS   Duarri A, Lin MC, Fokkens MR, Meijer M, Smeets CJ, Nibbeling EA, Boddeke E, Sinke RJ, Kampinga HH, Papazian DM, Verbeek DS
  TITLE     Spinocerebellar ataxia type 19/22 mutations alter heterocomplex Kv4.3 channel function and gating in a dominant manner.
  JOURNAL   Cell Mol Life Sci 72:3387-99 (2015)
            DOI:10.1007/s00018-015-1894-2
REFERENCE   PMID:31145571
  AUTHORS   Matilla-Duenas A, Volpini V
  TITLE     Spinocerebellar Ataxia Type 37
  JOURNAL   GeneReviews (1993)
REFERENCE   PMID:29939198
  AUTHORS   Corral-Juan M, Serrano-Munuera C, Rabano A, Cota-Gonzalez D, Segarra-Roca A, Ispierto L, Cano-Orgaz AT, Adarmes AD, Mendez-Del-Barrio C, Jesus S, Mir P, Volpini V, Alvarez-Ramo R, Sanchez I, Matilla-Duenas A
  TITLE     Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.
  JOURNAL   Brain 141:1981-1997 (2018)
            DOI:10.1093/brain/awy137
REFERENCE   PMID:31721251
  AUTHORS   Swinnen B, Robberecht W, Van Den Bosch L
  TITLE     RNA toxicity in non-coding repeat expansion disorders.
  JOURNAL   EMBO J e101112 (2019)
            DOI:10.15252/embj.2018101112
REFERENCE   PMID:31755042
  AUTHORS   Ishikawa K, Nagai Y
  TITLE     Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31).
  JOURNAL   Neurotherapeutics 10.1007/s13311-019-00804-6 (2019)
            DOI:10.1007/s13311-019-00804-6
REFERENCE   PMID:23607545
  AUTHORS   Niimi Y, Takahashi M, Sugawara E, Umeda S, Obayashi M, Sato N, Ishiguro T, Higashi M, Eishi Y, Mizusawa H, Ishikawa K
  TITLE     Abnormal RNA structures (RNA foci) containing a penta-nucleotide repeat (UGGAA)n in the Purkinje cell nucleus is associated with spinocerebellar ataxia type 31 pathogenesis.
  JOURNAL   Neuropathology 33:600-11 (2013)
            DOI:10.1111/neup.12032
REFERENCE   PMID:21683323
  AUTHORS   Kobayashi H, Abe K, Matsuura T, Ikeda Y, Hitomi T, Akechi Y, Habu T, Liu W, Okuda H, Koizumi A
  TITLE     Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement.
  JOURNAL   Am J Hum Genet 89:121-30 (2011)
            DOI:10.1016/j.ajhg.2011.05.015
REL_PATHWAY hsa03050  Proteasome
            hsa04020  Calcium signaling pathway
            hsa04140  Autophagy - animal
            hsa04141  Protein processing in endoplasmic reticulum
            hsa04210  Apoptosis
            hsa04724  Glutamatergic synapse
            hsa04730  Long-term depression
KO_PATHWAY  ko05017
///
